SCHEMBL9709528

SCHEMBL9709528

CCCCCCCCCC(=O)N[C@@H](C=O)[C@@H](O)[C@H](O)[C@H](O)CO

nearest known ligand 0.59

Predicted protein targets (top 12)

geneUniProtsupporting neighboursconfidence
MEN1 O00255 3/20 0.54
KMT2A Q03164 3/20 0.54
DEGS1 O15121 3/20 0.50
FAAH O00519 2/20 0.49
MAPK1 P28482 1/20 0.49
CETP P11597 3/20 0.48
THRB P10828 1/20 0.48
ASAH1 Q13510 1/20 0.45
DNM1 Q05193 1/20 0.44
ASAH2 Q9NR71 1/20 0.44
PLA2G4A P47712 2/20 0.43
CERT1 Q9Y5P4 2/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1623032 1.00 MEN1 (0.54) MEN1KMT2ADEGS1FAAHMAPK1
SCHEMBL1623366 1.00 MEN1 (0.54) MEN1KMT2ADEGS1FAAHMAPK1
SCHEMBL679503 1.00 MEN1 (0.54) MEN1KMT2ADEGS1FAAHMAPK1
SCHEMBL1623037 1.00 MEN1 (0.54) MEN1KMT2ADEGS1FAAHMAPK1
SCHEMBL10958796 1.00 MEN1 (0.54) MEN1KMT2ADEGS1FAAHMAPK1
SCHEMBL5821483 1.00 MEN1 (0.54) MEN1KMT2ADEGS1FAAHMAPK1
SCHEMBL1622513 1.00 MEN1 (0.54) MEN1KMT2ADEGS1FAAHMAPK1
SCHEMBL5185943 1.00 MEN1 (0.54) MEN1KMT2ADEGS1FAAHMAPK1
SCHEMBL557791 0.99 MEN1 (0.51) MEN1KMT2ADEGS1FAAHMAPK1
SCHEMBL5326495 0.99 MEN1 (0.51) MEN1KMT2ADEGS1FAAHMAPK1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-4323561-A Process of enhancing immmunogenic response in mammals by the administration of synthetic glycolipid adjuvants TEMPLE UNIVERSITY OF THE COMMONWEALTH SYSTEM OF HIGHER EDUCATION (US) 1982-04-06 US claimed
WO-1992016230-A1 LIPID A ANALOG/IMMUNOGENIC CARRIER CONJUGATES, THE USE THEREOF AS VACCINES AND POLYVALENT HYPERIMMUNE GAMMAGLOBULINS UNIVAX BIOLOGICS INCORPORATED (US) 1992-10-01 WO disclosed
US-4323561-A Process of enhancing immmunogenic response in mammals by the administration of synthetic glycolipid adjuvants TEMPLE UNIVERSITY OF THE COMMONWEALTH SYSTEM OF HIGHER EDUCATION (US) 1982-04-06 US disclosed